Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders

Schizophrenia Research

Volumn 33, Issue 1-2, 1998, Pages 113-118

  Diwan, Aparna ^a,b   Castine, Michael ^b   Pomerleau, Cynthia S ^c   Meador Woodruff, James H ^b,c,d   Dalack, Gregory W ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Mood disorders; Schizoaffective disorder; Schizophrenia; Smoking

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; NICOTINE;

ADULT; AFFECTIVE NEUROSIS; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DEPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MOOD; NEUROBIOLOGY; PREVALENCE; PRIORITY JOURNAL; SCHIZOIDISM; SCHIZOPHRENIA; SELF REPORT; SUBSTANCE ABUSE;

ADULT; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; MOOD DISORDERS; PREVALENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; TOBACCO USE DISORDER;

EID: 0032494261     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00045-0     Document Type: Article

References (37)

1. Adler, L.E., Hoffer, L.D., Wiser, A., Freedman, R., 1993. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 150, 1856-1861.
2. Alterman, A.I., Erlden, F.R., Murphy, E., 1981. Alcohol abuse in the psychiatric hospital population. Addict. Behav. 6, 69-73.
3. Centers for Disease Control and Prevention, 1996. Cigarette smoking among adults - United States, 1994. Morbidity and Mortality Weekly Report 45(27), 588-590.
4. Cicchetti, D.V., Sparrow, S.S., 1981. Developing criteria for establishing interrater reliability of specific items: applications to the assessment of adaptive behavior. Am. J. Ment. Defic. 86 (2), 127-137.
5. Cohen, E., Henkin, I., 1993. Prevalence of substance abuse by seriously mentally ill patients in a partial hospital program. Hosp. Commun. Psychiatry 44, 178-180.
6. Covey, L.S., Hughes, D.C., Glassman, A.H., Blazer, D.G., George, L.K., 1994. Ever-smoking, quitting, and psychiatric disorders: evidence from Durham, North Carolina, Epidemiologic Catchment Area. Tobacco Control 3, 222-227.
7. Dalack, G.W., Meador-Woodruff, J.H., 1996. Smoking, smoking withdrawal and schizophrenia: case reports and a review of literature. Schizophr. Res. 22, 133-141.
8. Dawe, S., Gerada, C., Russell, M.A.H., Gray, J.A., 1995. Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology 117, 110-115.
9. de Leon, J., Dadvand, M., Canuso, C., White, A.O., Stanilla, J.K., Simpson, G.M., 1995. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry 152, 453-455.
10. Dixon, L., Haas, G., Weiden, P., Sweeney, J., Francis, A., 1990. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr. Bull. 16, 69-79.
11. Dixon, L., Haas, G., Weiden, P.J., Sweeney, J., Frances, A.J., 1991. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry 148, 224-230.
12. El-Guebaly, N., Hodgins, D.C., 1992. Schizophrenia and substance abuse: prevalence issues. Can. J. Psychiatry 37, 704-710.
13. George, T.P., Sernyak, M.J., Ziedonis, D.M., Woods, S.W., 1995. Effects of clozapine on smoking in chronic schizophrenic outpatients. J. Clin. Psychiatry 56, 344-346.
14. Glassman, A.H., Helzer, J.E., Covey, L.S., Cottler, L.B., Stetner, F., Tipp, J.E., Johnson, J., 1990. Smoking, smoking cessation, and major depression. J. Am. Med. Assoc. 264, 1546-1549.
15. Glassman, A.H., 1993. Cigarette smoking: implications for psychiatric illness. Am. J. Psychiatry 150, 546-553.
16. Glassman, A.H., Covey, L.S., Dalack, G.W., Stetner, F., Rivelli, S.K., Fleiss, J., Cooper, T.B., 1993. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin. Pharmacol. Ther. 54, 670-679.
17. Glynn, S.M., Sussman, S., 1990. Why patients smoke (letter). Hosp. Commun. Psychiatry 41, 1027-1028.
18. Goff, D.C., Henderson, D.C., Amico, E., 1992. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry 149, 1189-1194.
19. Hamera, E., Schneider, J.K., Deviney, S., 1995. Alcohol, cannabis, nicotine and caffeine use and symptom distress in schizophrenia. J. Nerv. Ment. Dis. 183 (9), 559-565.
20. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerstrom, K.-O., 1991. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict. 86, 1119-1127.
21. Hughes, J.R., Hatsukami, D.K., Mitchell, J.E., Dahlgren, L.A., 1986. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry 143, 993-997.
22. Jeste, D.V., Gladsjo, J.A., Lindamer, L.A., Lacro, J.P., 1996. Medical comorbidity in schizophrenia. Schizophr. Bull. 22 (3), 413-430.
23. Leonard, S., Adams, C., Breese, C.R., Adler, L.E., Bickford, P., Byerley, W., Coon, H., Griffith, J.M., Miller, C., Myles-Worsley, M., Nagamoto, H.T., Rollins, Y., Stevens, K.E., Waldo, M., Freedman, R., 1996. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22 (3), 431-445.
24. Lohr, J.B., Flynn, K., 1992. Smoking and schizophrenia. Schizophr. Res. 8, 93-102.
25. McEvoy, J.P., Freudenreich, O., Levin, E.D., Rose, J.E., 1995a. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119, 124-126.
26. McEvoy, J., Freudenreich, O., McGee, M., VanderZwaag, C., Levin, E., Rose, J., 1995b. Clozapine decreases smoking in patients with chronic schizophrenia. Biol. Psychiatry 37, 550-552.
27. McLellan, A., Luborsky, L., Woody, G.E., O'Brien, C.P., Druley, K.A., 1983. Predicting response to alcohol and drug abuse treatments. Arch. Gen. Psychiatry 40, 620-625.
28. McPhillips, M.A., Kelly, F.J., Barnes, T.R.E., Duke, P.J., Gene-Cos, N., Clark, K., 1997. Detecting comorbid substance misuse among people with schizophrenia in the community: a study comparing results of questionnaires with analysis of hair and urine. Schizophr. Res. 25, 141-148.
29. Mueser, K., Yarnold, P.R., Levinson, D.F., Singh, H., Bellack, A.S., Kee, K., Morrison, R.L., Yadalam, K.G., 1990. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull. 16, 31-56.
30. Mueser, K.T., Yarnold, P.R., Bellack, A.S., 1992. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr. Scand. 85, 48-55.
31. Regier, D.A., Farma, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.J., Goodwin, F.K., 1990. Comorbidity of mental disorders with alcohol and other drug abuse: results from Epidemiological Catchment Area Study. J. Am. Med. Assoc. 264, 2511-2518.
32. Richard, M.L., Liskow, B.I., Perry, P.J., 1985. Recent psychostimulant use in hospitalized schizophrenics. J. Clin. Psychiatry 46, 79-83.
33. Sandyk, R., Kay, S.R., 1991. Tobacco addiction as a marker of age at onset of schizophrenia. Int. J. Neurosci. 57, 259-262.
34. Schneier, F.R., Siris, S.G., 1983. A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. J. Nerv. Ment. Dis. 175, 641-652.
35. Selzer, J.A., Lieberman, J.A., 1993. Schizophrenia and substance abuse. Psychiatr. Clin. North Am. 16 (2), 401-412.
36. Spitzer, R.L., Williams, J.B.W., Gibbon, M. and First, M.B., 1989. Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P, 9/1/89 Version). Biometrics Research Department, New York State Psychiatry Institute, New York, NY.
37. Ziedonis, D.M., Kosten, T.R., Glazer, W.M., Frances, R.J., 1994. Nicotine dependence and schizophrenia. Hosp. Commun. Psychiatry 45, 204-206.